OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Chronic inflammation generates damage-associated molecular patterns (DAMPs) such as DNA that impact immune responses. DNA is sensed to activate the Stimulator of Interferon Genes (STING) adaptor which may stimulate or suppress immunity. In some cancer models DNA suppresses anti-tumour immunity to promote tumour growth by inducing indoleamine 2,3 dioxygenase (IDO). STING agonists enhance anti-tumour immunity but fail to control tumour growth unless immune checkpoints are also disrupted. DNA sensing pathways can also be exploited to attenuate autoimmunity in several models of clinical autoimmune syndromes. Hence, STING agonists can be used to manipulate immune balance in a range of chronic conditions.
